Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Abbott Vascular-Cardiac Therapies

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Abbott Vascular-Cardiac Therapies

Regulatory records
1
Linked recall entries
0
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 1 FDA record to the applicant name Abbott Vascular-Cardiac Therapies. 1 entry is a PMA supplement. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Jan 12, 2026 to Jan 12, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code NIO appears in 1 of the 1 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P110043, with 1 linked entry. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.

Applicant mailing address recorded by FDA: 3200 Lakeside Dr., Santa Clara, CA, 95054. Recorded on P110043/S015, decision dated Jan 12, 2026.

Changes described in PMA records

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

Regulatory record history

Product / regulatory recordCompanyPathwayDecision dateSource
Abbott Vascular-Cardiac TherapiesPMA supplementJan 12, 2026FDA
Source information

Source updated Nov 9, 2026. Retrieved Nov 21, 2026.